Discover 55 paid clinical trials in Kansas City, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With research focusing on conditions such as heart disease, high blood pressure, leukemia, and neurological disorders, Kansas City provides numerous opportunities for both healthy volunteers interested in paid studies, as well as those needing studies targeting a specific condition. The city’s leading medical centers are actively recruiting participants, providing access to the latest treatments and innovations in healthcare.
Filter
2
Filter results
Results: 55
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
for
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Location: Great Bend KS, Wichita KS, Garden City KS, Topeka KS,
Sponsor: NRG Oncology
Sex: All
Age: 45 - 70
Code: NCT05080673
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Great Bend KS, Garden City KS, Kansas City MO,
Sponsor: Children's Oncology Group
Sex: Female
Age: 0 - 39
Code: NCT06513962
Phase 3, Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
for
Metastatic Malignant Neoplasm in the Liver,
Location: Great Bend KS, Garden City KS, Kearney NE,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05040360
Phase 2, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Hutchinson KS, Wichita KS, Kansas City MO,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase 3, Recruiting
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Get alerts for new trials in your area by subscribing now
Prospective Study to Assess a Diagnostic Aid for Cancer
for
Cancer
Location: Hutchinson KS, Kansas City MO, Oklahoma City OK,
Sponsor: Harbinger Health
Sex: All
Age: 45+
Code: NCT07046260
Recruiting
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
for
Ulcerative Colitis, Crohn's Disease
Location: Hutchinson KS, Kansas City MO, Columbia MO,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06581328
Phase 4, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Hutchinson KS, Wichita KS, Kansas City KS,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase 3, Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Location: Salina KS, Topeka KS, Lawrence KS, Olathe KS,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06958328
Phase 3, Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Salina KS, Westwood KS, Kansas City KS,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06532279
Phase 2, Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers